newsfilter
← Latest News
PR Newswire·

Synaptogenix Announces $15 Million Private Placement with Existing Investors

Topline data from NIH-supported Phase 2 clinical trial for advanced AD patients expected during the current quarter NEW YORK, Nov. 18, 2022 /PRNewswire/ -- Synaptogenix, Inc. (NASDAQ:SNPX) ("Synaptogenix" or the